 | | Good Afternoon! | Hey, everyone. It's Adam from Elite Trade Club. Here’s what moved the market today. |
|
| | | | Markets 📈 | Wall Street remains undecided after a mixed start to the week. Stock markets showed increased volatility ahead of the planned tariff introduction. | DJIA [-0.03%] S&P 500 [+0.38%]
|
| Nasdaq [+0.87%] Russell 2K [-0.06%]
|
|
|
|
| | Market-Moving News 📈 | Automotive | GM Outpaces Auto Industry with First-Quarter Retail Growth | | General Motors (NYSE: GM) posted strong U.S. vehicle sales in the first quarter, driven by increased demand for electric vehicles and full-size SUVs. New models like the Cadillac Escalade IQ and Optiq helped bolster the automaker’s performance across key categories. | Buyers responded positively to GM’s latest offerings, especially within the crossover and entry-level SUV segments. Sales in these areas contributed to the company’s outperformance relative to industry expectations. Analysts had projected minimal growth, but GM’s gains exceeded early estimates. | Competitors such as Hyundai and Honda also posted first-quarter gains, though at a slower pace. Meanwhile, Ford reported a slight decline in overall vehicle sales, mainly due to the discontinuation of one of its models. | March activity capped a strong quarter for GM. Retail traffic increased, and dealerships reported heightened consumer interest across various regions. Some consumers appeared to act earlier than planned, contributing to the lift in first-quarter sales figures. | Industry data pointed to robust retail sales across the sector. Dealers saw rising foot traffic and stronger inventory turnover compared to last year. GM’s results suggest a solid foothold in traditional and electric vehicle categories. | General Motors continues to expand its EV lineup while maintaining strength in high-demand vehicle classes. Product launches and model refreshes remain key to the company’s retail momentum. |
|
| | Resource Sector Watch (Sponsored) | On Behalf of Azincourt Energy Corp | | | Five years ago, UEC was a tiny uranium stock. Now, it’s a $3.11 billion powerhouse. | This small uranium junior is sitting on prime assets and could be next. | *Examples that we provide of share price increases pertaining to a particular Issuer from one referenced date to another represent an arbitrarily chosen time period and are no indication whatsoever of future stock prices for that Issuer and are of no predictive value. Our stock profiles are intended to highlight certain companies for YOUR further investigation; they are NOT stock recommendations or constitute an offer or sale of the referenced securities. |
|
| | Consumer Products | Court Blocks Johnson & Johnson’s $10B Talc Proposal in Ongoing Legal Battle | | Johnson & Johnson (NYSE: JNJ) encountered a major legal setback after a U.S. bankruptcy judge rejected its proposed $10 billion settlement to resolve tens of thousands of lawsuits tied to its talc-based products. | Claimants allege the company’s baby powder and other talc items caused ovarian cancer, leading to over 60,000 active lawsuits. This ruling marks the third time a court has dismissed the company’s bankruptcy approach related to talc claims. | Executives confirmed they will return to court to fight the remaining lawsuits individually. They also reversed the $7 billion previously set aside for the defunct settlement plan. | Legal opponents have challenged the bankruptcy filings, stating that Johnson & Johnson is not experiencing financial hardship that would justify such a legal shield. | Federal court records show that earlier bankruptcy attempts received similar pushback. Plaintiffs and bankruptcy watchdogs continue to argue that the company should not use bankruptcy court to manage mass tort liability. | In response to the latest rejection, Johnson & Johnson reiterated that its talc products are safe and asbestos-free. In 2020, the company halted sales of talc-based baby powder in the U.S. and shifted to a cornstarch-based formula. | Court documents indicate the company will not appeal this ruling. Johnson & Johnson also reaffirmed confidence in its financial projections and ongoing business performance. | Healthcare analysts continue to monitor the case closely, as the litigation remains one of the most high-profile corporate liability matters in recent years. |
|
| | | How to Get Rich in a Market Crash |  | How to Get Rich in a Market Crash |
|
| |
|
| | Technology (Sponsored) | | | The Magnificent Seven—Apple, Microsoft, Alphabet, Amazon, Nvidia, Meta Platforms, and Tesla—have redefined market leadership. | But as their record-breaking growth slows, the focus shifts to the next generation of industry leaders. | Analysts have identified seven global companies with the potential to rise above the rest in 2025. | These stocks are poised to surge, fueled by growing market share, robust cash flows, and innovative strategies that set them apart from the competition. | (By clicking the link above, you will get this free report and a free subscription to MarketBeat's daily email newsletter. You are also agreeing to the terms of our privacy policy. Unsubscribe at any time.) | Position yourself to capture the next wave of market-defining opportunities. | Click here to uncover the “7 Stocks That Will Be Magnificent in 2025” before the market catches on. | (By clicking the link above, you will get this free report and a free subscription to MarketBeat's daily email newsletter. You are also agreeing to the terms of our privacy policy. Unsubscribe at any time.) |
|
| | Consumer Tech | Roblox Expands Ad Tools with Google to Tap Gaming Monetization | | Roblox Corporation (NYSE: RBLX) has introduced a new video advertising format to enhance its growing ad business. The company also partnered with Google to extend the reach of these tools to advertisers worldwide. | Players can now opt to watch video ads, up to 30 seconds long, in exchange for in-game benefits such as boosts or resources. This format, known as rewarded video, allows brands to engage users without disrupting gameplay. | Advertisers will soon access this format directly through Google’s ad platform, creating a streamlined pathway to Roblox’s highly active audience. Brands and agencies can purchase inventory either directly or via programmatic tools, broadening accessibility across markets. | Executives see this move as a step toward diversifying Roblox’s revenue beyond virtual purchases. The company continues to invest in measurement partnerships with firms like Nielsen, Cint, and DoubleVerify to provide better performance insights for advertisers. | Platform data shows over 85 million daily active users, most aged 13 and older. Roblox aims to leverage this large Gen Z user base to offer brands unique advertising opportunities that align with digital-native behaviors. | Plans include rolling out additional ad formats, such as dynamic billboards, through Google Ad Manager. Roblox supports advertisers seeking long-term engagement by embedding monetization tools inside immersive experiences. | Industry observers will watch how this partnership influences the broader adoption of in-game ads in the gaming sector. |
|
| | Top Winners and Losers 🔥 | | | Newsmax Inc [NMAX] $234.00 (+180.21%) | Conservative-oriented TV broadcaster Newsmax made a strong debut on the NYSE. The stock started at $10 and skyrocketed to over $80 on Monday. Today, it broke above $240, becoming one of the most successful IPOs in years. | Nutex Health Inc [NUTX] $71.40 (+51.82%) | Nutex Health’s stock price hit the highest level in nearly two years after reporting strong Q4 and annual results for 2024. The company’s total revenue surged over 90% to $479.9 million. | Cloudastructure Inc [CSAI] $5.70 (+28.38%) | Cloudastructure, which provides cloud-based video surveillance services, broke above the $5 mark on positive 2024 results, with revenue up 124% year-over-year. |
| |
|
| | | | | | Corcept Therapeutics [CORT] $91.93 (-19.52%) | Corcept Therapeutics was the biggest winner on Monday after positive trial results for its ovarian cancer treatment. However, on Tuesday, the stock fell due to a healthy correction amid persistent bearish pressure on biotech stocks. | Palvella Therapeutics Inc [PVLA] $23.57 (-15.79%) | Palvella Therapeutics declined by over 10% after posting quarterly and annual financial updates. The company reported a net loss of over $17.4 million for 2024, after registering an income of nearly $18 million in the previous year. | Gorilla Technology Group Inc [GRRR] $25.13 (-15.10%) | Gorilla Technology was one of the worst performers today despite posting robust financials that exceeded expectations. Investors are concerned with allegations that some of its executives engaged in securities fraud, although the company dismisses this. |
| |
| | |
| | | | That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback! | Thanks for reading. I'll see you at the next open! | Best Regards,
— Adam G.
Elite Trade Club |
|
| | | | Click here to get our daily newsletter straight to your cell for free. | P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP. |
| |
|
|
|
